In the Finance (Miscellaneous ) Act 2023, the Pharmacy Act has been amended to –
- facilitate registration of locally manufactured products under a technology transfer agreement with good manufacturing practices of the World Health Organization; and
- disallow a public body, under the Public Procurement Act, to exclude locally manufactured product duly registered with the Pharmacy Board from being tendered.